- About TapImmune
- News & Media
- Contact Us
TapImmune Inc., a Jacksonville-based immunotherapy company, has received fast track status from the U.S. Food & Drug Administration to study the use of its vaccine TPIV 200 to treat a certain form of ovarian cancer. by: Charlie Patton Immunotherapy is a type of cancer treatment designed...
Events & Marathon to take place in Jacksonville, Florida on February 12-14, 2016 JACKSONVILLE, FLORIDA, February 10, 2016 / TapImmune, Inc. (TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and...